These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17897055)

  • 1. Macrophage migration inhibitory factor: a therapeutic target across inflammatory diseases.
    Hoi AY; Iskander MN; Morand EF
    Inflamm Allergy Drug Targets; 2007 Sep; 6(3):183-90. PubMed ID: 17897055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosis.
    Santos LL; Morand EF
    Clin Chim Acta; 2009 Jan; 399(1-2):1-7. PubMed ID: 18838066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New therapeutic target in inflammatory disease: macrophage migration inhibitory factor.
    Morand EF
    Intern Med J; 2005 Jul; 35(7):419-26. PubMed ID: 15958113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage migration inhibitory factor: a potential therapeutic target for rheumatoid arthritis.
    Kim KW; Kim HR
    Korean J Intern Med; 2016 Jul; 31(4):634-42. PubMed ID: 27169879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current developments of macrophage migration inhibitory factor (MIF) inhibitors.
    Xu L; Li Y; Sun H; Zhen X; Qiao C; Tian S; Hou T
    Drug Discov Today; 2013 Jun; 18(11-12):592-600. PubMed ID: 23466524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIF in autoimmunity and novel therapeutic approaches.
    Stosic-Grujicic S; Stojanovic I; Nicoletti F
    Autoimmun Rev; 2009 Jan; 8(3):244-9. PubMed ID: 18721909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis.
    Morand EF; Leech M; Bernhagen J
    Nat Rev Drug Discov; 2006 May; 5(5):399-410. PubMed ID: 16628200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus.
    Bilsborrow JB; Doherty E; Tilstam PV; Bucala R
    Expert Opin Ther Targets; 2019 Sep; 23(9):733-744. PubMed ID: 31414920
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity suppresses microglia-mediated inflammatory responses.
    Zhang Y; Gu R; Jia J; Hou T; Zheng LT; Zhen X
    Clin Exp Pharmacol Physiol; 2016 Nov; 43(11):1134-1144. PubMed ID: 27543936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritis.
    Santos LL; Morand EF
    Wien Med Wochenschr; 2006 Jan; 156(1-2):11-8. PubMed ID: 16465610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases.
    Thiele M; Donnelly SC; Mitchell RA
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36180072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage Migration Inhibitory Factor (MIF): A Glucocorticoid Counter-Regulator within the Immune System.
    Calandra T; Bucala R
    Crit Rev Immunol; 2017; 37(2-6):359-370. PubMed ID: 29773026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage migration inhibitory factor in rheumatoid arthritis.
    Morand EF; Leech M
    Front Biosci; 2005 Jan; 10():12-22. PubMed ID: 15576336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage migration inhibitory factor and glucocorticoid sensitivity.
    Aeberli D; Leech M; Morand EF
    Rheumatology (Oxford); 2006 Aug; 45(8):937-43. PubMed ID: 16705047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is macrophage migration inhibitory factor a therapeutic target in systemic lupus erythematosus?
    Hoi AY; Morand EF; Leech M
    Immunol Cell Biol; 2003 Oct; 81(5):367-73. PubMed ID: 12969324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of macrophage migration inhibitory factor-novel approach for the treatment of immunoinflammatory disorders.
    Cvetkovic I; Stosic-Grujicic S
    Int Immunopharmacol; 2006 Oct; 6(10):1527-34. PubMed ID: 16919824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Targeting of a Disease-Related Conformational Isoform of Macrophage Migration Inhibitory Factor Ameliorates Inflammatory Conditions.
    Thiele M; Kerschbaumer RJ; Tam FW; Völkel D; Douillard P; Schinagl A; Kühnel H; Smith J; McDaid JP; Bhangal G; Yu MC; Pusey CD; Cook HT; Kovarik J; Magelky E; Bhan A; Rieger M; Mudde GC; Ehrlich H; Jilma B; Tilg H; Moschen A; Terhorst C; Scheiflinger F
    J Immunol; 2015 Sep; 195(5):2343-52. PubMed ID: 26209628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity.
    Flaster H; Bernhagen J; Calandra T; Bucala R
    Mol Endocrinol; 2007 Jun; 21(6):1267-80. PubMed ID: 17389748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIF, MIF alleles, and prospects for therapeutic intervention in autoimmunity.
    Bucala R
    J Clin Immunol; 2013 Jan; 33 Suppl 1(Suppl 1):S72-8. PubMed ID: 22968741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF).
    Burger-Kentischer A; Göbel H; Kleemann R; Zernecke A; Bucala R; Leng L; Finkelmeier D; Geiger G; Schaefer HE; Schober A; Weber C; Brunner H; Rütten H; Ihling C; Bernhagen J
    Atherosclerosis; 2006 Jan; 184(1):28-38. PubMed ID: 15921687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.